首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat.
【2h】

The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat.

机译:心钠素与血管紧张素II在控制大鼠钠和水排泄中的相互作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The present study was designed to determine how the natriuretic and diuretic actions of atrial natriuretic peptides were modulated by circulating angiotensin II. 2. In sodium pentobarbitone-anaesthetized rats, administration of bolus doses of atriopeptin III (1000 ng kg-1) had no effect on blood pressure, renal blood flow, or glomerular filtration rate but caused reversible increases (all P less than 0.001) in urine flow, of 53.9 +/- 14.4 microliters kg-1 min-1, absolute sodium excretion, of 13.4 +/- 2.9 mumol kg-1 min-1 and fractional sodium excretion of 3.26 +/- 0.74%. Similar effects were seen following a second dose of the atriopeptin III. 3. Following blockade of the renin-angiotensin system with captopril (900 micrograms kg-1 h-1), control levels of blood pressure and haemodynamics were unchanged but there were significant (all P less than 0.001) increases in urine flow, from 39.96 +/- 5.05 to 88.70 +/- 8.41 microliters kg-1 min-1, absolute sodium excretion, from 8.35 +/- 1.08 to 21.62 +/- 1.62 mumol kg-1 min-1 and fractional sodium excretion, from 3.82 +/- 0.23 to 5.34 +/- 0.32%. Under these conditions, atriopeptin III-induced increases in urine flow (110.2 +/- 8.7 versus 43.9 +/- 6.2 microliters kg-1 min-1) absolute (24.0 +/- 1.8 versus 9.3 +/- 1.2 mumol kg-1 min-1) and fractional (5.16 +/- 0.24 versus 2.08 +/- 0.33%) sodium excretions were significantly (P less than 0.001) greater.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.本研究旨在确定循环血管紧张素II如何调节心钠素的利钠和利尿作用。 2.在戊巴比妥钠麻醉的大鼠中,推注剂量的atriopeptin III(1000 ng kg-1)对血压,肾血流量或肾小球滤过率没有影响,但引起可逆的增加(所有P均小于0.001)。尿流量为53.9 +/- 14.4微升kg-1 min-1,绝对钠排泄为13.4 +/- 2.9 mumol kg-1 min-1,钠排泄分数为3.26 +/- 0.74%。在第二次服用三肽atriopeptin III后,看到了类似的效果。 3.卡托普利(900微克kg-1 h-1)阻断肾素-血管紧张素系统后,血压和血流动力学的控制水平未变,但尿流显着增加(所有P均小于0.001),从39.96开始+/- 5.05至88.70 +/- 8.41微升kg-1 min-1,绝对钠排泄,从8.35 +/- 1.08至21.62 +/- 1.62 mumol kg-1 min-1和部分钠排泄,从3.82 + / -0.23至5.34 +/- 0.32%。在这些条件下,三肽由atriopeptin III引起的尿液流量增加(110.2 +/- 8.7对43.9 +/- 6.2微升kg-1 min-1)绝对值(24.0 +/- 1.8对9.3 +/- 1.2μmolkg-1分钟-1)和分数(5.16 +/- 0.24对2.08 +/- 0.33%)的钠排泄量显着增加(P小于0.001)(摘要以250字截断)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号